BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 6379620)

  • 1. [Effect of the serum of patients with an active form of pulmonary sarcoidosis on the biological activity of lymphocytes and leukocytes of healthy persons].
    Wolska-Goszka L
    Pol Tyg Lek; 1984 Feb; 39(7):209-13. PubMed ID: 6379620
    [No Abstract]   [Full Text] [Related]  

  • 2. [Immunologic disorders in patients with an active form of pulmonary sarcoidosis].
    Wolska-Goszka L
    Wiad Lek; 1984 May; 37(10):777-81. PubMed ID: 6390975
    [No Abstract]   [Full Text] [Related]  

  • 3. Inhibitory effect of serum on lymphocyte transformation by phytohemagglutinin in patients with intrathoracic sarcoidosis.
    Terasawa M
    Sci Rep Res Inst Tohoku Univ Med; 1983 Dec; 30(1-4):69-85. PubMed ID: 6205448
    [No Abstract]   [Full Text] [Related]  

  • 4. [Leukocyte migration inhibition test, effect of the serum of patients with sarcoidosis].
    Lenzini L; Rottoli L; Rottoli P
    Boll Soc Ital Biol Sper; 1975 Nov; 51(21):1587-9. PubMed ID: 1231847
    [No Abstract]   [Full Text] [Related]  

  • 5. [Leukocyte migration inhibition test using collagen antigen in fibrosing alveolitis and pulmonary sarcoidosis].
    Shukurova RA; Berchenko VV; Belokrinitskiĭ DV; Kornev BM
    Klin Med (Mosk); 1991 Sep; 69(9):43-5. PubMed ID: 1803147
    [No Abstract]   [Full Text] [Related]  

  • 6. Studies of peripheral blood monocytes in pulmonary sarcoidosis.
    Rømer FK; Christiansen SE; Kragballe K; Herlin T; Madsen M
    Clin Exp Immunol; 1984 Nov; 58(2):357-63. PubMed ID: 6094058
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Biologic markers of sarcoidosis. Apropos of a case of pulmonary and cutaneous sarcoidosis].
    Guinand O; Hofer R; De Senarclens C
    Rev Med Suisse Romande; 1983 Sep; 103(9):737-42. PubMed ID: 6648182
    [No Abstract]   [Full Text] [Related]  

  • 8. [Cell migration inhibition factor in the presence of lung extract in patients with productive pulmonary tuberculosis].
    Bernal-Madrazo MA; Celis-Barragán ME; Olivares-Lugo A; Cicero-Sabido R
    Gac Med Mex; 1982 Jun; 118(6):236-8. PubMed ID: 6751919
    [No Abstract]   [Full Text] [Related]  

  • 9. [Comparative study of tuberculin sensitivity in sarcoidosis and tuberculosis patients].
    Goncharova SI; Chernushenko EF
    Probl Tuberk; 1983 Jan; (1):39-43. PubMed ID: 6835965
    [No Abstract]   [Full Text] [Related]  

  • 10. [Inhibitory effect on rabbit peritoneal leukocyte and macrophage chemotaxis by sera from patients with pulmonary sarcoidosis: significance of serum chemotactic inhibitor in sarcoidosis].
    Okuyama Y
    Hokkaido Igaku Zasshi; 1982 Mar; 57(2):197-209. PubMed ID: 7118051
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum-mediated stimulation and inhibition of neutrophil locomotion in sarcoidosis.
    Schmekel B; Håkansson L; Hällgren R; Stålenheim G; Venge P
    Eur J Respir Dis; 1984 Nov; 65(8):592-9. PubMed ID: 6519214
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Lymphocytotoxicity of serum and its development during ganglio-pulmonary sarcoidosis].
    Brun J; Biot N; Carraz M; Veysseyre C; Prevot J; Perrin-Fayolle M; Traeger J
    Lyon Med; 1969 Jan; 221(4):141-57. PubMed ID: 5779297
    [No Abstract]   [Full Text] [Related]  

  • 13. [Interleukin-2 (IL-2) production by activated T cells in Patients with pulmonary sarcoidosis].
    Nagai S
    Nihon Kyobu Shikkan Gakkai Zasshi; 1987 Sep; 25(9):977-83. PubMed ID: 3502154
    [No Abstract]   [Full Text] [Related]  

  • 14. Application of the leukocyte migration inhibition (LMI) test in clinical management of diseases of the respiratory system.
    Pregowski W; Janicka G
    Arch Immunol Ther Exp (Warsz); 1976; 24(3):367-71. PubMed ID: 962513
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Determination of a factor inhibiting migration of leukocytes to brain antigens, its concentration in serum and spontaneous leukocyte migration in multiple sclerosis].
    Loĭko TP; Ierusalimskiĭ AP; Lozovoĭ VP
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1986; 86(2):187-90. PubMed ID: 3518311
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Modification of the leukocyte migration inhibition test and its use in the differential diagnosis of sarcoidosis and tuberculosis].
    Batian AN
    Probl Tuberk; 1987; (12):47-9. PubMed ID: 3444825
    [No Abstract]   [Full Text] [Related]  

  • 17. Immunological monitoring in lung cancer: use of the leukocyte migration inhibition assay.
    Abai AM; Fekete B
    Haematologia (Budap); 1982; 15(1):111-25. PubMed ID: 6749608
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Lymphocyte markers in sarcoidosis and tuberculosis].
    Munker M; Munker R; Kiggen E; Cujnik F; Thierfelder S
    Prax Klin Pneumol; 1984 Oct; 38(10):456-9. PubMed ID: 6334290
    [No Abstract]   [Full Text] [Related]  

  • 19. Cellular immunity during follow-up of patients with sarcoidosis of varying duration.
    Selroos O; Nikinmaa B; Koivunen E; Riska H; Tiitinen H; Weber T
    Clin Exp Immunol; 1982 Oct; 50(1):25-33. PubMed ID: 7172509
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [New data concerning sarcoidosis immunology].
    Ispasiu M
    Ftiziologia; 1973; 22(3):251-60. PubMed ID: 4576114
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.